Intra-Cellular Therapies
ITCI
#1817
Rank
S$12.19 B
Marketcap
$115.03
Share price
-0.21%
Change (1 day)
46.86%
Change (1 year)

P/S ratio for Intra-Cellular Therapies (ITCI)

P/S ratio as of November 2024 (TTM): 14.8

According to Intra-Cellular Therapies's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 7.90. At the end of 2024 the company had a P/S ratio of 12.6.

P/S ratio history for Intra-Cellular Therapies from 2014 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202412.6-15.25%
202314.9-25.87%
202220.1-61.45%
202152.2-54.05%
2020114-99.64%
2019> 1000
2018N/A
2017N/A
2016N/A-100%
2015> 10007862.53%
2014951

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
100 577.74%๐Ÿ‡บ๐Ÿ‡ธ USA
3.37-77.14%๐Ÿ‡บ๐Ÿ‡ธ USA
12.6-14.64%๐Ÿ‡บ๐Ÿ‡ธ USA